CRTI Exceptional Translational Working Group (TWG) Award
The objective of the Cancer Research Translational Initiative (CRTI) Translational Working Group (TWG) awards is to make an impact on the translational goals of the TWGs in research leading to novel approaches in cancer diagnosis, prevention, or treatment.
A liquid biopsy-derived proteogenomics as a prognostic biomarker for 177Lu-PSMA-617 radioligand therapy in patients with prostate cancer
Justin Drake, PhD, Department of Pharmacology, Medical School
Emmanuel Antonarakis, MD, Division of Hematology, Oncology, and Transplantation, Medical School
Scott Dehm, PhD, Department of Laboratory Medicine and Pathology, Medical School
Utilizing molecular tracing to study therapy resistance mechanisms in ER+ breast cancer
Thu Truong, PhD, Biochemistry Molecular Biology and Biophysics, College of Biological Sciences
Nuri Temiz, PhD, Institute for Health Informatics, Office of Academic Clinical Affairs
Zohar Sachs, MD, PhD, Division of Hematology, Oncology, and Transplantation, Medical School
Heather Beckwith, MD, Division of Hematology, Oncology, and Transplantation, Medical School
Engineered Exosome Based Treatment Strategy for Colorectal Cancer
Subree Subramanian, PhD, Department of Surgery, Medical School
The two faces of FOXA1 alterations in metastatic prostate cancer, and their therapeutic implications
Justin Hwang, PhD, Division of Hematology, Oncology and Transplantation, Medical School
Mechanisms of progression of myelodysplastic syndrome to fatal secondary acute myeloid leukemia
Zohar Sachs, MD, PhD, Division of Hematology, Oncology and Transplantation, Medical School
Targeting Potential Early Drivers of Oral Carcinogenesis
Rajaram Gopalakrishnan, PhD, Department of Diagnostic and Biological Sciences School of Dentistry
Effects of Kava on Anxiety and Stress in Cancer Survivors
Naomi Fujioka, MD, Department of Medicine, Medical School
Identification and targeting of protein complexes in breast cancer
Julie Ostrander, PhD, Hematology, Oncology, Transplantation, Medical School
DNA Repair Inhibition to Kill APOBEC3B‐Positive Clear Cell Ovarian Carcinoma
Britt Erickson, MD, Obstetrics, Gynecology and Women's Health, Medical School
Targeted Proteomics to Identify AR Splice Variants in Prostate Cancer
Justin Drake, PhD, Department of Pharmacology, Medical School
Prognostic and therapeutic Significance of T‐Cell Senescence and Exhaustion in Acute Lympoblastic Leukemia
Fiona He, MD, Hematology, Oncology, Transplantation, Medical School
Imaging CD133 in Aggressive Variant Prostate Cancer by Positron Emission Tomography
Aaron LeBeau, PhD, Department of Pharmacology, Medical School
Generation of a screening platform and antigen receptors for therapeutically targeting gastrointestinal malignancies with engineered lymphocytes
Ingunn Stromnes, PhD, Department of Microbiology and Immunology, Medical School
Targeting RALB signaling to enhance NK immunotherapy for acute myeloid leukemia
Criag Eckfeldt, MD, PhD, Department of Medicine, Medical School
Breast Cancer Translational Working Group Pilot Project - Creation of a Tissue Microarray
Andrew Nelson, MD, PhD, Department of Laboratory Medicine and Pathology, Medical School
Novel Tissue-Based Biomarkers of Graft-Versus-Host-Disease
Shernan Holtan, MD, Division of Hematology, Oncology and Transplantation, Medical School
Skin Health Study Repository for Translational Research: Phase 2
DeAnn Lazovich, MPH, PhD, Epidemiology & Community Health, School of Public Health
Heather Nelson, MPH, PhD, Epidemiology & Community Health, School of Public Health